Herbal substance, acteoside, alleviates intestinal mucositis in mice

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Reinke, Daniel ^a,b   Kritas, Stamatiki ^a   Polychronopoulos, Panagiotis ^c   Skaltsounis, Alexios L ^c   Aligiannis, Nektarios ^c   Tran, Cuong D ^a,b  

^a Gastroenterology Unit   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACTEOSIDE; METALLOTHIONEIN; METHOTREXATE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DUODENUM; ENTERITIS; ENZYME ACTIVITY; HISTOPATHOLOGY; ILEUM; JEJUNUM; MALE; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PROPHYLAXIS; TREATMENT DURATION;

EID: 84921326549     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/327872     Document Type: Article

References (34)

1. J.-L. Pico, A. Avila-Garavito, and P. Naccache, and quot;Mucositis: its occurrence, consequences, and treatment in the oncology setting, and " Oncologist, vol. 3, no. 6, pp. 446-451, 1998.
2. S. T. Sonis and K. A. Costello, and quot;Adatabase formucositis induced by cancer chemotherapy, and " European Journal of Cancer-Part B: Oral Oncology, vol. 31, no. 4, pp. 258-260, 1995.
3. B. A. E. de Koning, J. M. vanDieren, D. J. Lindenbergh-Kortleve et al., and quot;Contributions ofmucosal immune cells to methotrexateinducedmucositis, and " International Immunology, vol. 18, no. 6, pp. 941-949, 2006.
4. S. T. Sonis, and quot;Mucositis: the impact, biology and therapeutic opportunities of oral mucositis, and " Oral Oncology, vol. 45, no. 12, pp. 1015-1020, 2009.
5. R. M. Logan, A. M. Stringer, J. M. Bowen et al., and quot;The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs, and " Cancer Treatment Reviews, vol. 33, no. 5, pp. 448-460, 2007.
6. N. Boukhettala, J. Leblond, S. Claeyssens et al., and quot;Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake, and " The American Journal of Physiology: Endocrinology and Metabolism, vol. 296, no. 1, pp. E182-E190, 2009.
7. M. R. Posner and R. I. Haddad, and quot;Novel agents for the treatment of mucositis, and " Journal of Supportive Oncology, vol. 5, no. 9, pp. 33-39, 2007.
8. E. B. Rubenstein, D. E. Peterson, M. Schubert et al., and quot;Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis, and " Cancer, vol. 100, no. S9, pp. 2026-2046, 2004.
9. D. M. Keefe, S. T. Sonis, and J. M. Bowen, and quot;Emerging drugs for chemotherapy-inducedmucositis, and quot;ExpertOpiniononEmerging Drugs, vol. 13, no. 3, pp. 511-522, 2008.
10. D. M. Keefe, M. M. Schubert, L. S. Elting et al., and quot;Updated clinical practice guidelines for the prevention and treatment of mucositis, and " Cancer, vol. 109, no. 5, pp. 820-831, 2007.
11. L. Negri, R. Lattanzi, E. Giannini et al., and quot;Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior, and " The Journal of Neuroscience, vol. 26, no. 25, pp. 6716-6727, 2006.
12. T. H. Wright, R. Yazbeck, K. A. Lymn et al., and quot;The herbal extract, Iberogast, improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis, and " Cancer Biology and Therapy, vol. 8, no. 10, pp. 923-929, 2009.
13. W. T. Y. Loo, L. Jin, L. W. C. Chow, M. N. B. Cheung, and M. Wang, and quot;Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients, and " Expert Opinion on Investigational Drugs, vol. 19, no. 1, pp. S91-S100, 2010.
14. A. M. Díaz, M. J. Abad, L. Fernández, A. M. Silván, J. de Santos, and P. Bermejo, and quot;Phenylpropanoid glycosides from Scrophularia scorodonia: in vitro anti-inflammatory activity, and " Life Sciences, vol. 74, no. 20, pp. 2515-2526, 2004.
15. B. Konuklugil and O Bahadir, and quot;Phenylpropanoid glycosides from Linum olympicum, and " Turkish Journal of Chemistry, vol. 28, no. 6, pp. 741-744, 2004.
16. Y. P. Hwang, H. G. Kim, J. H. Choi et al., and quot;Acteoside inhibits PMA-induced matrix metalloproteinase-9 expression via CaMK/ERK-and JNK/NF-B-dependent signaling, and " Molecular Nutrition and Food Research, vol. 55, supplement 1, pp. S103-S116, 2011.
17. A. Güvenc, Y. Okada, E. K. Akkol, H. Duman, T. Okuyama, and I. Calis, and quot;Investigations of anti-inflammatory, antinociceptive, antioxidant and aldose reductase inhibitory activities of phenolic compounds from Sideritis brevibracteata, and " Food Chemistry, vol. 118, no. 3, pp. 686-692, 2010.
18. M. Hausmann, F. Obermeier, D. H. Paper et al., and quot;In vivo treatmentwith the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis, and " Clinical and Experimental Immunology, vol. 148, no. 2, pp. 373-381, 2007.
19. Q. Xiong, K. Hase, Y. Tezuka, T. Namba, and S. Kadota, and quot;Acteoside inhibits apoptosis in D-Galactosamine and lipopolysaccharide-induced liver injury, and " Life Sciences, vol. 65, no. 4, pp. 421-430, 1999.
20. T. Genovese, I. Paterniti, E. Mazzon et al., and quot;Efficacy of treatment with verbascoside, biotechnologically produced by Syringa vulgaris plant cell cultures in an experimental mice model of spinal cord trauma, and " Naunyn-Schmiedebergs Archives of Pharmacology, vol. 382, no. 4, pp. 331-345, 2010.
21. J. Y. Lee, E.-R. Woo, and K. W. Kang, and quot;Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation, and " Journal of Ethnopharmacology, vol. 97, no. 3, pp. 561-566, 2005.
22. C. D. Tran, S. Sundar, and G. S. Howarth, and quot;Dietary zinc supplementation and methotrexate-induced small intestinal mucositis in metallothionein-knockout and wild-type mice, and " Cancer Biology and Therapy, vol. 8, no. 17, pp. 1662-1667, 2009.
23. A. Dahlqvist, and quot;Method for assay of intestinal disaccharidases, and " Analytical Biochemistry, vol. 7, no. 1, pp. 18-25, 1964.
24. D. L. Eaton and B. F. Toal, and quot;Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biologival tissues, and " Toxicology and Applied Pharmacology, vol. 66, no. 1, pp. 134-142, 1982.
25. G. S. Howarth, G. L. Francis, J. C. Cool, X. Xu, R. W. Byard, and L. C. Read, and quot;Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats, and " The Journal of Nutrition, vol. 126, no. 10, pp. 2519-2530, 1996.
26. R. Medeiros, R. D. S. Prediger, G. F. Passos et al., and quot;Connecting TNF-α signaling pathways to iNOS expression in a mouse model of Alzheimers disease: relevance for the behavioral and synaptic deficits induced by amyloid protein, and " Journal of Neuroscience, vol. 27, no. 20, pp. 5394-5404, 2007.
27. D. M. Templeton and M. G. Cherian, and quot;Toxicological significance ofmetallothionein, and quot;Methods in Enzymology, vol. 205, pp. 11-24, 1991.
28. J. Abel and N. de Ruiter, and quot;Inhibition of hydroxyl-radicalgenerated DNA degradation by metallothionein, and " Toxicology Letters, vol. 47, no. 2, pp. 191-196, 1989.
29. M. Fotin-Mleczek, F. Henkler, A. Hausser et al., and quot;Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-B activation, and " The Journal of Biological Chemistry, vol. 279, no. 1, pp. 677-685, 2004.
30. K. Hayashi, T. Nagamatsu, M. Ito, H. Yagita, and Y. Suzuki, and quot;Acteoside, a component of Stachys sieboldii MIQ, may be a promising antinephritic agent (3): effect of acteoside on expression of intercellular adhesionmolecule-1 in experimental nephritic glomeruli in rats and cultured endothelial cells, and " The Japanese Journal of Pharmacology, vol. 70, no. 2, pp. 157-168, 1996.
31. Q. Xiong, Y. Tezuka, T. Kaneko et al., and quot;Inhibition of nitric oxide by phenylethanoids in activated macrophages, and " European Journal of Pharmacology, vol. 400, no. 1, pp. 137-144, 2000.
32. L. Speranza, S. Franceschelli, M. Pesce et al., and quot;Antiinflammatory effects in THP-1 cells treated with verbascoside, and " Phytotherapy Research, vol. 24, no. 9, pp. 1398-1404, 2010.
33. Y. Al-Gindan, M. Shawarby, A. Noto, and C. G. Taylor, and quot;Intestinal inflammation in rats induces metallothionein in colonic submucosa, and " Journal of Clinical Biochemistry and Nutrition, vol. 44, no. 2, pp. 131-141, 2009.
34. M. Brüwer, K. W. Schmid, K. A. Metz, C. F. Krieglstein, N. Senninger, and G. Schürmann, and quot;Increased expression of metallothionein in inflammatory bowel disease, and " Inflammation Research, vol. 50, no. 6, pp. 289-293, 2001.